Organon & Co. (7XP)
XDUS
Real-time Data
06:00 AM
Day's Range
12.1452 wk Range
4.97Overview - 7XP - Organon & Co.
Key Statistics
Valuation
Enterprise Value
8.07B
P/E (Trailing)
‪17.04‬
PEG Ratio
‪-0.63‬
Price / Book
‪3.20‬
EV / EBITDA
‪4.73‬
Profitability
Gross Margin
‪54.36%‬
Profit Margin
‪53.29%‬
Operating Margin
‪14.94%‬
Return on Assets
‪1.45%‬
Return on Equity
‪24.86%‬
Ownership
Shares Outstanding
262.60M
Price stats
50-Day Avg
‪11.85‬
200-Day Avg
‪9.57‬
Dividends
Frequency
Quarterly
Peers - 7XP - Organon & Co.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on XDUS.
- 7XPXDUSOrganon & Co.+31.68%52-week change17.05P/E (Trailing)‪53.29%‬Profit Margin
- 6MKXDUSMerck & Co., Inc.+43.34%52-week change17.66P/E (Trailing)‪74.80%‬Profit Margin
- IDPXDUSBiogen Inc.+40.40%52-week change23.81P/E (Trailing)‪75.69%‬Profit Margin
- BAYAXDUSBayer AG Sponsored ADR+38.89%52-week change-11.74P/E (Trailing)‪58.75%‬Profit Margin
- BAYNXDUSBayer AG+38.13%52-week change-12.00P/E (Trailing)‪58.75%‬Profit Margin
- AMGXDUSAmgen Inc.+32.95%52-week change26.92P/E (Trailing)‪67.24%‬Profit Margin
- BRMXDUSBristol-Myers Squibb Company+31.19%52-week change16.07P/E (Trailing)‪71.08%‬Profit Margin
Profile Summary - 7XP - Organon & Co.
About
Organon & Co. is a global pharmaceutical company focused on women’s health, biosimilars, and established prescription medicines. Organon & Co. develops and delivers health solutions across a broad portfolio that includes therapies and medical devices used in reproductive health, contraception, fertility, dermatology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
